Clinical and demographic characteristics of patients (pts) treated with vemurafenib in real-world setting

被引：0
|
作者：
Sadetsky, N. [1 ]
Corvino, F. [2 ]
Surinach, A. [2 ]
Goodman, G. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Genesis Res LLC, Hoboken, NJ USA
来源：
MELANOMA RESEARCH | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P062
引用
收藏
页码：E42 / E42
页数：1
相关论文
共 50 条
  • [21] CHARACTERISTICS AND TREATMENTS OF PATIENTS WITH SJOGREN'S SYNDROME IN A REAL-WORLD SETTING
    Gonzalez-Najera, Carlos
    Taylor, Steven
    Crawford, Sean
    Narasimhan, Premkumar
    Shao, Xiao
    Li Jun
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1161 - 1162
  • [22] Real-world disease burden for patients (pts) with myelofibrosis (MF) treated with ruxolitinib (RUX).
    Gerds, Aaron Thomas
    Kish, Jonathan
    Parikh, Kejal
    Liassou, Djibril
    Miller, Talia
    Copher, Ronda
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Clinical characteristics and outcomes associated with molecular status and treatment with vemurafenib in metastatic melanoma (MM) in a real-world setting: Comparison of four groups.
    Kwapisz, Dorota Malgorzata
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] Characteristics and Outcomes of Rheumatoid Arthritis Patients Treated With Upadacitinib in Real-world Canadian Clinical Practice
    Appleton, Tom
    Patel, Jayesh
    Girard, Tanya
    Bailey, Fiona
    Jones, Hannah
    Durand, Caylib
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 833 - 833
  • [25] "Real-world" eligibility for aducanumab depends on clinical setting and patients' journey
    Padovani, Alessandro
    Caratozzolo, Salvatore
    Rozzini, Luca
    Pilotto, Andrea
    Benussi, Alberto
    Tedeschi, Gioacchino
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (02) : 626 - 628
  • [26] Large infarct core patients treated with endovascular therapy in a real-world setting
    Wellington, Daniel J.
    Donnelly, Joseph
    Hong, Jae Beom
    Diprose, William
    Barber, Alan
    CEREBROVASCULAR DISEASES, 2024, 53 : 85 - 85
  • [27] Performance Characteristics of Breezhaler® and Aerolizer® in the Real-World Setting
    Mathieu Molimard
    Ioannis Kottakis
    Juergen Jauernig
    Sonja Lederhilger
    Ivan Nikolaev
    Clinical Drug Investigation, 2021, 41 : 415 - 424
  • [28] Early insights into the characteristics of tralokinumab patients in a real-world setting in the United States
    Chovatiya, Raj
    Balu, Sanjeev
    Kim, Yestle
    Althoff, Amanda G.
    Rasouliyan, Lawrence
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [29] CLINICAL CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION IN A REAL-WORLD COHORT OF PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB
    Chiorean, Michael V.
    Sharma, Puza P.
    Salese, Leonardo
    Gruben, David
    Woolcott, John
    Khan, Nabeel
    GASTROENTEROLOGY, 2021, 160 (06) : S229 - S230
  • [30] Clinical characteristics and outcomes of patients with advanced hepatocellular carcinoma treated with immunotherapy: A real-world retrospective study
    Chergui, Adel
    Gadde, Eswar
    Tolu, Seda Serra
    Acuna-Villaorduna, Ana
    Kabarriti, Rafi
    Goel, Sanjay
    Kaubisch, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345